摘要:
The present invention relates to compounds of formula (I) wherein X is N or P; -SO3- is -O-S(O)2 -or -S(O)2-O-; and n and R1 to R5 are defined below, and to their use as additives for electrolyte compositions, in particular in electrolyte compositions for lithium batteries.
摘要:
The present invention provides bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and compositions comprising such analogs. The present invention also provides pharmaceutical compositions containing these bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and methods for their use. All of these analogs are particularly useful for the treatment and/or prophylaxis of conditions that involve the Na+K+Cl− co-transporter or GABAA receptor including but not limited to addictive disorders, Alzheimer's Disease, anxiety disorders, ascites, autism, bipolar disorder, cancer, depression, endothelial corneal dystrophy, edema, epilepsy, glaucoma, Huntington's Disease, insomnia, ischemia, migraine, migraine with aura, neuropathic pain, nociceptive neuralgia, nociceptive pain, ocular diseases, pain, Parkinson's disease, personality disorders, postherpetic neuralgia, psychosis, schizophrenia, seizure disorders, tinnitus, and withdrawal syndromes.
摘要翻译:本发明提供了布美他尼,呋塞米,吡咯他尼,阿佐塞米,和托拉塞米类似物和组合物,包含寻求类似物。 因此,本发明提供了含有本文布美他尼,呋塞米,吡咯他尼,阿佐塞米,和托拉塞米类似物和它们的使用方法的药物组合物。 所有合成类似物是用于和/或病症的预防确实涉及的Na + K +氯共转运或GABA A受体包括但不限于成瘾障碍,阿尔茨海默氏病,焦虑症,腹水,孤独症,双相性特别适用于治疗 疾病,癌症,抑郁症,内皮角膜营养不良,水肿,癫痫,青光眼,亨廷顿氏病,失眠,脑缺血,偏头痛,有先兆偏头痛,神经性疼痛,伤害性神经痛,伤害性疼痛,眼部疾病,疼痛,帕金森氏症,人格障碍,带状疱疹 神经痛,精神病,精神分裂症,癫痫症,耳鸣,和戒断症状。
摘要:
The present invention provides bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and compositions comprising such analogs. The present invention also provides pharmaceutical compositions containing these bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and methods for their use. All of these analogs are particularly useful for the treatment and/or prophylaxis of conditions that involve the Na+K+Cl− co-transporter or GABAA receptor including but not limited to addictive disorders, Alzheimer's Disease, anxiety disorders, ascites, autism, bipolar disorder, cancer, depression, endothelial corneal dystrophy, edema, epilepsy, glaucoma, Huntington's Disease, insomnia, ischemia, migraine, migraine with aura, neuropathic pain, nociceptive neuralgia, nociceptive pain, ocular diseases, pain, Parkinson's disease, personality disorders, postherpetic neuralgia, psychosis, schizophrenia, seizure disorders, tinnitus, and withdrawal syndromes.